Peter is a Senior Associate on the Frazier Life Sciences team focused on identifying and evaluating new investment opportunities in public companies.
Peter joined the Frazier Life Sciences team as a Senior Associate in 2022, where he focuses on identifying and evaluating new public investment opportunities.
Prior to joining Frazier, Peter was a management consultant with McKinsey & Company’s life sciences practice, where he led teams engaging with leading organizations across R&D and business development projects.
Peter received his M.D. from the Icahn School of Medicine at Mount Sinai and his B.A. in Health & Societies with a Health Care Markets & Finance concentration from the University of Pennsylvania.